Get the Stockscreener App
1.23
3.91%
-0.05
After Hours:
1.25
0.02
+1.63%
Geron Corp stock is traded at $1.23, with a volume of 4.98M.
It is down -3.91% in the last 24 hours and down -6.11% over the past month.
Geron Corp is a clinical-stage biopharmaceutical company focused on the research and development of cancer treatments. The company's drug in development, Imelstat, is being tested for the treatment of myelodysplastic syndromes, which are disorders of the blood, and myelofibrosis, which is a rare blood cancer affecting bone marrow. The company earns revenue through collaboration agreements, milestones, royalties, and licensing arrangements. Geron possesses various rights to this drug. The company operates as a single segment being, the development of therapeutic products for oncology.
See More
Previous Close:
$1.28
Open:
$1.3
24h Volume:
4.98M
Relative Volume:
0.61
Market Cap:
$784.76M
Revenue:
$29.48M
Net Income/Loss:
$-201.19M
P/E Ratio:
-3.8438
EPS:
-0.32
Net Cash Flow:
$-216.50M
1W Performance:
-0.81%
1M Performance:
-6.11%
6M Performance:
-10.87%
1Y Performance:
-71.13%
1-Day Range:
$1.22
$1.30
1-Week Range:
$1.21
$1.30
52-Week Range:
$1.09
$4.50
Geron Corp Stock (GERN) Company Profile
Name
Geron Corp
Sector
Industry
Phone
(650) 473-7700
Address
919 EAST HILLSDALE BOULEVARD, FOSTER CITY, CA
Compare GERN with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
GERN
Geron Corp
|
1.23 | 816.66M | 29.48M | -201.19M | -216.50M | -0.32 |
|
VRTX
Vertex Pharmaceuticals Inc
|
417.21 | 108.30B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
652.91 | 69.37B | 14.25B | 4.58B | 3.56B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
481.59 | 62.38B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
ARGX
Argen X Se Adr
|
821.97 | 51.50B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
166.95 | 34.94B | 398.11M | -1.03B | -868.57M | -5.7032 |
Geron Corp Stock (GERN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-10-25 | Resumed | Goldman | Sell |
| May-08-25 | Downgrade | Scotiabank | Sector Outperform → Sector Perform |
| Feb-27-25 | Downgrade | B. Riley Securities | Buy → Neutral |
| Feb-26-25 | Downgrade | H.C. Wainwright | Buy → Neutral |
| Nov-05-24 | Initiated | H.C. Wainwright | Buy |
| Oct-16-24 | Initiated | Scotiabank | Sector Outperform |
| Sep-09-24 | Initiated | Leerink Partners | Outperform |
| Apr-30-24 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Apr-29-24 | Initiated | TD Cowen | Buy |
| Mar-15-24 | Reiterated | Needham | Buy |
| Sep-12-23 | Upgrade | Goldman | Neutral → Buy |
| Mar-28-23 | Initiated | Goldman | Neutral |
| Oct-28-22 | Initiated | Wedbush | Outperform |
| Jul-28-22 | Resumed | B. Riley Securities | Buy |
| Nov-02-21 | Initiated | Robert W. Baird | Outperform |
| Feb-18-21 | Resumed | B. Riley Securities | Buy |
| Aug-03-20 | Initiated | Stifel | Buy |
| Nov-19-19 | Resumed | B. Riley FBR | Buy |
| Sep-03-19 | Initiated | H.C. Wainwright | Buy |
| Aug-15-19 | Initiated | Cantor Fitzgerald | Overweight |
| Apr-09-19 | Upgrade | Needham | Hold → Buy |
| Jan-31-19 | Upgrade | B. Riley FBR | Neutral → Buy |
| Oct-02-18 | Downgrade | B. Riley FBR | Buy → Neutral |
| Jul-05-18 | Initiated | B. Riley FBR, Inc. | Buy |
| Sep-13-16 | Reiterated | FBR & Co. | Outperform |
| Sep-13-16 | Reiterated | FBR Capital | Outperform |
| Dec-07-15 | Reiterated | Piper Jaffray | Overweight |
| Apr-21-15 | Initiated | Oppenheimer | Outperform |
| Jun-12-14 | Upgrade | MLV & Co | Hold → Buy |
| Mar-12-14 | Downgrade | MLV & Co | Buy → Hold |
| Dec-10-13 | Reiterated | MLV & Co | Buy |
| Dec-10-13 | Upgrade | Needham | Hold → Buy |
| Nov-08-13 | Reiterated | MLV & Co | Buy |
| Oct-16-13 | Initiated | MLV & Co | Buy |
| Aug-30-12 | Initiated | Stifel Nicolaus | Buy |
| Jun-28-12 | Initiated | Needham | Hold |
View All
Geron Corp Stock (GERN) Latest News
Why Geron Corporation (GON) stock attracts HNW investorsJuly 2025 Setups & Verified Momentum Stock Watchlist - newser.com
Is Geron Corporation stock cheap at current valuationAnalyst Upgrade & Real-Time Stock Entry Alerts - newser.com
Is Geron Corporation stock a good choice for value investorsMarket Performance Summary & Fast Exit and Entry Strategy Plans - newser.com
What hedge fund activity signals for Geron Corporation stock2025 Stock Rankings & Consistent Profit Alerts - newser.com
Will Geron Corporation stock deliver shareholder valuePortfolio Performance Report & Technical Confirmation Trade Alerts - newser.com
Geron (Nasdaq: GERN) sets Nov 5 Q3 results release, webcast planned before market open - Stock Titan
Is Geron Corporation (GON) stock ideal for retirement investorsQuarterly Portfolio Summary & Trade Opportunity Analysis - newser.com
How strong is Geron Corporation (GON) stock earnings growthWeekly Risk Summary & Weekly Market Pulse Alerts - newser.com
What analyst consensus says on Geron Corporation stockLong Setup & Accurate Technical Buy Alerts - newser.com
What earnings revisions data tells us about Geron Corporation2025 Trade Ideas & AI Powered Market Entry Strategies - newser.com
Is Geron Corporation (GON) stock a safe buy pre earningsWeekly Trade Report & Free High Accuracy Swing Entry Alerts - newser.com
GERON (GERN) INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. is Investigating Geron Corporation on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm - GlobeNewswire Inc.
Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Stock Titan
Backtesting results for Geron Corporation trading strategiesJuly 2025 Action & Weekly High Potential Alerts - newser.com
What MACD trends signal for Geron Corporation (GON) stockEarnings Miss & Long-Term Growth Stock Strategies - newser.com
Will Geron Corporation stock gain from strong economyMarket Sentiment Review & Accurate Intraday Trade Tips - Trung tâm Dự báo KTTV quốc gia
Why Geron Corporation (GON) stock gets analyst attentionWeekly Loss Report & Daily Profit Focused Screening - Trung tâm Dự báo KTTV quốc gia
When is the best time to exit Geron CorporationWeekly Profit Report & Technical Buy Zone Confirmations - newser.com
Investment Review: How Geron Corporation stock performs during Fed tightening cyclesTrade Entry Report & Expert Curated Trade Setups - Trung tâm Dự báo KTTV quốc gia
Will Geron’s (GERN) New Commercial Team Reshape Its Long-term Competitive Position? - Yahoo Finance
Using data models to predict Geron Corporation stock movementEarnings Overview Summary & Long-Term Safe Investment Plans - newser.com
Geron Corp Announces Board and Executive Changes - TradingView
GERN 8-K: Director exit, COO/CCO depart; 12-month consulting pact - Stock Titan
Geron (GERN): Assessing Valuation After Leadership Changes to Drive RYTELO Growth and Strategic Transformation - Yahoo Finance
Geron Announces Executive Leadership Transitions - TipRanks
Geron (GERN) Restructures Leadership with Key Executive Appointm - GuruFocus
Geron (GERN) Announces Executive Leadership Changes to Boost Com - GuruFocus
Geron announces leadership changes as part of strategic realignment - Investing.com
4 New Executives, Including Chief Commercial Officer, Join Geron to Strengthen Commercial Strategy Oct 2025 - Stock Titan
What makes Geron Corporation stock attractive to growth fundsBreakout Watch & High Return Trade Guides - newser.com
Geron CorporationCommon Stock (NQ: GERN - FinancialContent
Is Geron Corporation (GON) stock undervalued at current priceQuarterly Profit Review & High Accuracy Swing Entry Alerts - newser.com
Combining machine learning predictions for Geron CorporationMarket Trend Summary & Risk Managed Trade Strategies - newser.com
Long term hold vs stop loss in Geron CorporationQuarterly Profit Summary & Verified Momentum Stock Alerts - newser.com
Geron's (GERN) "Sell (D-)" Rating Reaffirmed at Weiss Ratings - MarketBeat
Geron Corp Stock (GERN) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.71%
1.60%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):